Plus Property Plant And Equipment Net from 2010 to 2024

PSTV Stock  USD 1.28  0.02  1.59%   
Plus Therapeutics Property Plant And Equipment Net yearly trend continues to be fairly stable with very little volatility. Property Plant And Equipment Net is likely to outpace its year average in 2024. Property Plant And Equipment Net is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects Plus Therapeutics' investment in assets used for production. View All Fundamentals
 
Property Plant And Equipment Net  
First Reported
2001-03-31
Previous Quarter
871 K
Current Value
697 K
Quarterly Volatility
1.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Plus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Plus Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 375.2 K, Selling General Administrative of 10.2 M or Selling And Marketing Expenses of 637 K, as well as many indicators such as Price To Sales Ratio of 1.06, Dividend Yield of 0.0022 or Days Sales Outstanding of 46.47. Plus financial statements analysis is a perfect complement when working with Plus Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Plus Therapeutics Correlation against competitors.
For more information on how to buy Plus Stock please use our How to Invest in Plus Therapeutics guide.

Latest Plus Therapeutics' Property Plant And Equipment Net Growth Pattern

Below is the plot of the Property Plant And Equipment Net of Plus Therapeutics over the last few years. It is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production. Plus Therapeutics' Property Plant And Equipment Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Plus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Net10 Years Trend
Pretty Stable
   Property Plant And Equipment Net   
       Timeline  

Plus Property Plant And Equipment Net Regression Statistics

Arithmetic Mean2,020,953
Geometric Mean1,892,456
Coefficient Of Variation37.92
Mean Deviation604,484
Median1,818,000
Standard Deviation766,357
Sample Variance587.3B
Range2.6M
R-Value(0.18)
Mean Square Error611.9B
R-Squared0.03
Significance0.52
Slope(30,900)
Total Sum of Squares8.2T

Plus Property Plant And Equipment Net History

2024M
20231.1 M
20221.6 M
20211.8 M
20202.5 M
2019M
20182.3 M

About Plus Therapeutics Financial Statements

Plus Therapeutics investors use historical fundamental indicators, such as Plus Therapeutics' Property Plant And Equipment Net, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Plus Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant And Equipment Net1.1 MM

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Plus Stock Analysis

When running Plus Therapeutics' price analysis, check to measure Plus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plus Therapeutics is operating at the current time. Most of Plus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Plus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plus Therapeutics' price. Additionally, you may evaluate how the addition of Plus Therapeutics to your portfolios can decrease your overall portfolio volatility.